Small study checks if common antibiotic quickly tackles rare lung infection
NCT ID NCT04287049
First seen Nov 17, 2025 · Last updated May 25, 2026 · Updated 21 times
Summary
This pilot study looked at how well the antibiotic azithromycin works alone during the first 14 days of treatment for Mycobacterium avium complex (MAC) lung disease. Ten adults with MAC lung disease took azithromycin daily, and researchers measured changes in bacteria levels in their sputum. The goal was to understand the drug's early bacteria-killing activity, not to test a cure or long-term control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.